Benetic has announced the signing of two major agreements, one that
grants Sigma-Aldrich license for the use of Benitec's RNAi
technology. Sigma's acquisition of an equity stake in Benitec also
signals its intentions regarding...
Serono has announced a mixed third quarter 2005 with product sales
and total revenues weaker than predicted. Its net income beat
market consensus but the company was hit by an $18.3 million (€15.2
million) one-off charge related to...
Bionovo has announced data identifying a novel class of Oestrogen
receptor-subtype modulators, which provides solid evidence of a
potentially safer alternative treatment to hormone therapy that
treats hot flashes and night sweats.
Research Dynamics have struck a deal with VirtualScopics in which
they have signed a non-exclusive partnership agreement to co-market
their clinical research services and technologies.
Dharmacon and Alcon are to collaborate on the discovery of new
therapies for eye disease using RNAi technology. The specificity
and novel molecular mechanism of RNAi may allow for the development
of safer and more effective drugs...
A recently published report has revealed that less than 13 per cent
of US consumers believe that information provided by pharmaceutical
companies is more trustworthy than healthcare information provided
by other organisations.
According to a new report, the emergence of antibacterial
resistance is set to push antibiotic R&D back into the
spotlight in an attempt to slow down the increasing levels of drug
resistance that could well erode the medical advances...
Roche has formed a research collaboration with Epitomics, giving
Roche a license to Epitomics' monoclonal antibody technology
(RabMab technology) for the discovery and development of monoclonal
antibodies to treat cancer and...
New Life Scientific and CureLab have identified an anti fungal
compound that represents a significant breakthrough as part of a
joint collaboration, which has demonstrated immunostimulating and
antibacterial properties.
According to a new report, worldwide revenues for cell and cytokine
therapies in regenerative medicine are set to reach $20.7 billion
(€17.3 billion) in 2010 in a sector that provides a viable
alternative to using drugs or other therapies.
Procyon has announced preclinical results for its lead HIV protease
inhibitor that has demonstrated cross-resistance profile and
multi-drug resistant strains of HIV-1 compared to other HIV
protease inhibitors, which are fast becoming...
Olympus Microscopes announces the launch of two new microscopy
products that aims to further improve live cell imaging conditions
that characterises drug development.
A new antibiotic that not only acts as a traditional antibiotic but
also acts on bacterial infections that have developed resistance to
existing types of antibiotic could herald the emergence of a new
tool to fight infections.
Scientists have demonstrated that a mouse virus that causes mammary
cancer can infect human cells. This latest study attempts to shed
light on a debate stretching back to the early 70's, which show
that a viral-like agent may...
Drugs, which stick to a key protein in the bloodstream, could help
to create drugs that are delivered more effectively to organs in
the body. The latest research, which points to a more effective
delivery of therapy, could improve...
Researchers have discovered a species of seaweed that could yield
new compounds with pharmaceutical potential, some of which showed
the potential to kill cancer cells, bacteria and even the HIV
virus.
A new technique that adds to the effectiveness of gene therapy has
made a breakthrough after it was revealed that the method had cured
phenylketonuria (PKU) in mice.
Enzo Biochem, announced that pre-clinical experiments with its
small molecule candidate suggests it would have applications in
strengthening bones weakened by age or as a consequence of certain
medications.
Researchers are developing breakthrough diabetes drugs that use
modified forms of a naturally occurring molecule produced by the
body. The approach characterises the major investments by the
biopharmaceutical industry to develop and...
Roche Molecular Systems and Primagen today entered talks to form a
collaboration that develops dry filter spot technology for HIV-1
viral load testing in the developing world.
Life sciences is to be given priority under a European Commission
(EU) framework, which focuses on creating a knowledge-based economy
to ensure increased funding for this industry.
Invitrogen has announced two additional acquisitions in the area of
nanotechnologcal tools for target and drug discovery, just as it
completes the earlier-announced purchase of Biosource
International.
Microbiologists from the University of Bradford in the UK believe
they may be closer to developing a vaccine that can protect newborn
babies from being infected by the common and potentially fatal
bacteria Group B Streptococcus.
Elusys Therapeutics' Anthrax drug candidate is to commence human
clinical trials after the biopharmaceutical company received
Institutional Review Board (IRB) approval. The drug, which has
already received "Fast Track"...
According to a new report, growing regulations in the European
pharmaceuticals industry is having a harmful effect on the market,
causing many companies to shift their bases to the United States
where the directives are more relaxed.
Tecan, supplier of compound and sample storage, releases the new HS
Pro series of automated microarray hybridisation stations, which
providing fully automated slide processing, from pre-hybridisation
to automated slide drying.
Scientists have synthesised a lab-made version of a human protein,
which alleviates symptoms of both acute and chronic arthritis. The
study opens new research avenues to better understand and develop
drug treatments for rheumatoid...
MerLion Pharmaceuticals has entered into a collaborative agreement
with Astellas Pharma to identify new anti-cancer drug candidates
derived from natural product chemistry.
Integra Biosciences has launched its next generation system that
enables automated filling of up to 540 Petri dishes at the push of
a button. The technology utilises an agar-spread function that
promises a 30 per cent saving on media...
Angiotech has announced the formation of a drug discovery and
development agreement with CombinatoRx that aims to focus on drug
treatments for peripheral vascular, coronary, and orthopaedic
disorders.
European researchers have come up with a basis for a drug that can
treat diabetes, cancer and prevent vessel occlusion. The
researchers believe that new compounds could be developed in the
future which are more selective, more effective...
US researchers have discovered a new immune cell that may play a
key role in inflammatory and autoimmune diseases, which raises the
prospect of finding ways to treat these disorders that include
asthma, arthritis, and multiple sclerosis...
Stem cells have the potential to become an effective diagnostic
tool singling out those susceptible of atherosclerosis, say
researchers. These cells could also help to predict regeneration of
heart cells following a heart attack.
According to new study, the virus that causes AIDS is becoming more
sensitive to drug treatments, contradicting a wealth of research
that demonstrates the emergence of drug resistant viral strains.
US scientists have designed a new receptor and enhanced bioassay
that is set to advance the drug discovery process for diseases such
as cystic fibrosis and Bartter's syndrome, tracking a drug's
activity inside the cell.
Animal activists' latest target in its campaign of terrorism has
centred on a chain of children's nurseries that has links with the
chemicals testing company, Huntingdon Life Sciences (HLS).
Research scientists have targeted alterations in a human
chromosome, which can be used to improve the diagnosis and
treatment of brain tumours in adults that currently account for
over 50 per cent of primary tumours.
Olympus has introduced three new additions to its cell* range,
which enable image capture and documentation, as well as
fluorescence applications that will prove useful for drug
discovery.
Researchers have claimed that a new microchip could cut animal
testing in the pharmaceutical industry as well as speed up drug
development. By increasing the efficiency of preclinical testing of
new drugs the new chip is also set...
Researchers in the US have uncovered a contributing factor in
interferon resistance of malignant melanoma cells. The finding
represents a step forward in understanding of this type of cancer
and the changes in gene and cellular signalling...
A newly discovered compound, which has revealed new links between
cell signalling pathways and cell migration, may suggest new
avenues for novel pharmaceutical therapies for treating a variety
of diseases, including cancer.
Genentech has announced that studies of Avastin in
platinum-refractory ovarian cancer patients have been discontinued
due to patients developing a serious bowel problem.
Upstate Group has released a new, cost efficient Western blotting
detection kit, which offers the highest signal-to-noise ratios of
any existing luminal peroxidase formulations on the market,
providing improved sensitivity and low...
A US researcher has provided one possible molecular explanation of
how IGF-1 receptor and the IRS-1 protein act as a key growth factor
that regulates cell and body size. The discovery has revealed
details as to how tumour cells proliferate...
PerkinElmer and Invitrogen enter into a strategic agreement to
streamline drug development in which the collaboration will combine
PerkinElmer's technology for ion channel drug discovery and
Invitrogen's voltage sensor probe...
Olympus introduces its CellCut laser microdissection system for the
life sciences industry, which eliminates any direct specimen
contact ensuring totally contamination-free samples.
According to a recent report, pharmacogenetics is unlikely to
become a reality within the next 15-20 years having been 'hyped' by
the media, who are unaware of the many gaps in current
understanding of how genetics relates...
Beckman Coulter has introduced its integrated cytometry solution
(ICS), which simplifies and automates customer processes to improve
productivity. The solution. becomes the first integrated system to
offer laboratory information system...
US scientists have claimed to have developed the next generation of
effective viral-based therapies for cancer in which 'terminator'
viruses are deployed to destroy primary tumours.